Fine needle biopsy (FNB) is an essential technique in cancer research for obtaining tissue samples with minimal invasiveness. This method uses a slender, hollow needle to collect cells from a tumor or suspicious area, allowing for cytological analysis. FNB is favored in oncology due to its accuracy and less invasive nature compared to conventional surgical biopsies, leading to reduced patient discomfort. The technique aids in early cancer detection, precise staging, and the assessment of metastatic spread. Enhanced by imaging technologies like ultrasound and CT guidance, FNB has improved in accuracy and safety. In the realm of cancer research, FNB is pivotal for personalized medicine, offering molecular and genetic insights that inform targeted treatments and enhance patient outcomes.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States